Dynorphin A (1–17)
Brain & neurobiology
PreclinicalResearch concerns opioid signaling, pain and stress biology, neuroinflammation, addiction related processes, and inflammatory/cardiovascular models.
Laboratory, computational, ex vivo or animal model research is the main evidence base.
What is Dynorphin A (1–17)?
Dynorphin A (1–17) is an endogenous prodynorphin derived opioid peptide employed in research on pain, stress, neuroinflammation and addiction related pathways; the catalogue entry denotes the research grade peptide.
Which research context has Dynorphin A (1–17) been associated with?
Dynorphin A (1–17) is associated with neuroscience research on opioid signalling, pain and stress biology, neuroinflammation, addiction related processes and inflammatory/cardiovascular models in preclinical systems.
What documentation is available for Dynorphin A (1–17)?
Dynorphin A (1–17): Batch documents are not yet linked on this site. Required evidence for this endogenous dynorphin opioid peptide includes batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and purity limits; peptide content and residual solvent/water information; and assay or bioactivity data as applicable. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Dynorphin A (1–17)?
Dynorphin A (1–17): Storage depends on the documented supplied presentation; as an endogenous dynorphin opioid peptide verify dry/lyophilised versus solution form, solvent or buffer composition, concentration, pH sensitivity, container closure compatibility and freeze/thaw tolerance to mitigate degradation and aggregation. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.